Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
about
GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synucleinNovel approach for accurate tissue-based protein colocalization and proximity microscopy.YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies.Pathological alpha-synuclein propagates through neural networksQuantitative neuropathological assessment to investigate cerebral multi-morbidity.Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease.Alpha-synuclein levels in blood plasma decline with healthy aging.Pattern of extrapyramidal signs in Alzheimer's diseaseRegional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition.α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule AssemblyReducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau.AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms.Imaging the role of amyloid in PD dementia and dementia with Lewy bodies.Challenges of multimorbidity of the aging brain: a critical update.Genetics and underlying pathology of dementia.Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies.Dementia With Lew Body: Impacts of Surgery.Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.Molecular Genetics of Neurodegenerative Dementias.Interactions of pathological proteins in neurodegenerative diseases.Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias.Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.Recent Increases in Hippocampal Tau Pathology in the Aging Japanese Population: The Hisayama Study.Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.Association of the CX3CR1-V249I Variant with Neurofibrillary Pathology Progression in Late-Onset Alzheimer's Disease.Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies.Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias.Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Regional Overlap of Pathologies in Lewy Body Disorders.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology.Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's diseaseCeftriaxone Treatment for Neuronal Deficits: A Histological and MEMRI Study in a Rat Model of Dementia with Lewy Bodies
P2860
Q27331743-1B6ABF48-D121-47D4-B4CD-96066EE4E7B6Q33753090-DF905647-00FE-490E-A8E4-07065100211EQ33784904-013FCDB0-2550-4E6F-B72C-4795C5B95036Q34100338-29B23C0C-A253-4EBD-B207-0AC37163A70EQ34584768-31FDF712-1C18-4C83-B651-9388234E7D22Q34591096-15F1E7DB-2A53-40A7-BD18-6D809ADAD3FEQ35284843-67B0D877-5677-4AA9-85D0-A644505F79C7Q36647417-4104A605-9FBF-42B4-8D83-175882B922E5Q36809349-F2FCFF6C-18C1-40C1-B9EA-D2AEA2502410Q37098905-CDCC7198-7790-461C-A303-1D3A6C73E477Q37127867-4A1981DC-ADB7-483E-B8F0-02276E04DCA9Q37407659-07019F53-270C-4C3C-8772-E147449EAAB4Q37633577-BF3E279E-2062-4684-9349-0A8ECF195DECQ37694473-9BE3B8CE-7DC2-4EB3-B063-426BC195A233Q38228098-F1DDD78B-BC31-40B0-A4B0-6DD7420FE14FQ38236878-8AEDB997-DC22-4174-9E02-37697DD380FFQ38310765-90A5B383-BC40-4696-A54B-BF24D9386C09Q38435692-0FD8618D-2850-4706-BEA7-EA49AD6FBFD0Q38501488-81BD88CE-C149-4CCE-ACFE-BDA908006F7FQ38802883-A589A20A-78A1-4133-BA28-90452E465D3EQ39035458-9110495D-292B-4D79-B092-3DAB73F479B8Q39236779-EEA15379-F3E6-4557-AB03-C71CD19524C0Q39346750-3A94791E-CD8C-437E-835D-738E1B9D058CQ40364232-EBC591A6-7B6B-4B07-9E3C-C0881F614896Q40550324-C7B4EC63-90D4-4099-86BA-02CA128AF566Q47362946-CE77926D-8668-41D4-B7BE-AF05BC40B461Q47655932-18217E48-1F4B-4500-AFC9-0D15DE5D435FQ47666324-5E5B82D8-AB2F-48A5-944A-4FA7FEF2BD5BQ48287129-16026AA2-6DDE-420E-86F2-FA4002A5EC57Q48361868-00716CC4-D141-43DF-B500-5D5FA3E1749DQ48550610-A172EB9C-7158-42D3-9927-402C08A08EBBQ48575031-6DBC658F-EE19-4906-932D-CF0347503BDEQ48616026-49D48CF8-DF3C-42A9-BA4D-0CFB0604B70FQ48949617-EE27E03B-16A4-4B72-9D95-C8372992BCA3Q49987358-DADDEB1B-6DF5-4068-92BD-6CE236AFA9FBQ50211142-BF2C9369-B765-4383-ACAF-23D602BD380DQ54982491-FD6A0A92-5F88-4B12-A5B7-4D26E2F00723Q55003043-04AF5516-F3F2-48C5-B713-DDD06E7B99CCQ57800439-7F2E881D-F9DE-4C47-B110-5C5F7F801248Q58805879-1BF4ABC4-9D94-4580-8528-1610C7372FCD
P2860
Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
@en
type
label
Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
@en
prefLabel
Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
@en
P2093
P2860
P1476
Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
@en
P2093
Alberto Lleó
Ellen Gelpi
Maria J Martí
Martí Colom-Cadena
Rafael Blesa
Sara Charif
P2860
P304
P356
10.1097/NEN.0000000000000018
P577
2013-12-01T00:00:00Z